( MENAFN - JCN NewsWire) FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the treatment of Early Alzheimer's disease LEQEMBI is the only ...
The defense submission Tuesday was similar to arguments at bail hearings where defense lawyers insisted that prosecutors had demonized sexual activity between consenting adults to create the case.